Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Indiva Ltd V.NDVA

Alternate Symbol(s):  NDVAF

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of... see more

TSXV:NDVA - Post Discussion

Indiva Ltd > FYI
View:
Post by HARJAY on Nov 24, 2023 9:25am

FYI

 

Globe says now seen as a good time to buy more Indiva

 

2023-11-23 07:38 ET - In the News

 

The Globe and Mail reports in its Thursday, Nov. 23, edition that Echelon Partners analyst Andrew Semple has upgraded Indiva to "speculative buy" from "hold." The Globe's David Leeder writes that Mr. Semple is the lone analyst covering the stock. He elevated his share target to 13 cents from 10 cents. Mr. Semple says in a note: "Our decision to upgrade the stock is the result of: 1) improved financial forecasts (and DCF valuation) while still maintaining a degree of conservatism relative to management's internal expectations, 2) an improved risk profile with a near term liquidity gap in our model now plugged, and 3) ahead of potential material catalysts for Canadian LPs and edibles manufacturers specifically. In addition, since we moved Indiva to a 'hold' rating, its shares have declined by 27 per cent. We view the risk/reward trade-off to now be much improved at current share price levels, and with demonstrated operational and balance sheet improvements. We believe it is an opportune time for investors to consider adding to positions." The Globe reported on Sept. 8, 2021, and Oct. 18, 2021, that Raymond James rated Indiva "strong buy" and "outperform." It was then worth 51 cents and 43.5 cents.

Be the first to comment on this post